RESEARCH TRIANGLE PARK, NC--(Marketwire - August 29, 2007) - On average, drug companies dedicate 66% of their early-stage marketing budgets to Phase II, according to a report, “Early-Stage Pharmaceutical Marketing Budgets: Preparing for Product Launch” (http://www.EarlyStageMarketing.com), published by business intelligence leader Cutting Edge Information.
